Growth hormone, insulin and aging: the benefits of endocrine defects
- PMID: 20851173
- PMCID: PMC3408075
- DOI: 10.1016/j.exger.2010.08.020
Growth hormone, insulin and aging: the benefits of endocrine defects
Abstract
Longevity of mice can be increased by spontaneous or experimentally induced mutations that interfere with the biosynthesis or actions of growth hormone (GH), insulin-like growth factor 1 (IGF-1), or insulin in the adipose tissue. The effects of GH resistance and deficiency of GH (along with thyrotropin and prolactin) on aging and lifespan are the most pronounced and best established of these mutations. Potential mechanisms linking these endocrine deficits with delayed aging and extended longevity include increased stress resistance, alterations in insulin and mammalian target of rapamycin (mTOR) signaling and metabolic adjustments. Physiological relationships deduced from the extreme phenotypes of long-lived mouse mutants appear to apply broadly, encompassing genetically normal ("wild-type") mice and other mammalian species. The role of GH in the control of human aging continues to be hotly debated, but recent data indicate that reduced somatotropic signaling provides protection from cancer and other age-related diseases and may promote old age survival.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures
References
-
- Alderman JM, Flurkey K, Brooks NL, Naik SB, Gutierrez JM, Srinivas U, Ziara KB, Jing L, Boysen G, Bronson R, Klebanov S, Chen X, Swenberg JA, Stridsberg M, Parker CE, Harrison DE, Combs TP. Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Exper Gerontol. 2009;44:26–33. - PMC - PubMed
-
- Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A. Long-lived growth hormone receptor knockout mice: Interaction of reduced insulin-like growth factor 1/insulin signaling and caloric restriction. Endocrinology. 2005;146:851–60. - PubMed
-
- Bartke A. Life extension in the dwarf mouse. In: Conn PM, editor. Handbook of models for the study of human aging. Elsevier Academic Press; 2006. pp. 403–414.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
